TROZX | VIHAX | TROZX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 8.858 | 5.296 | 167% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 8.38B | 141% |
Annual Yield % from dividends | 3.37 | 4.87 | 69% |
Returns for 1 year | 16.71 | 11.72 | 143% |
Returns for 3 years | 18.42 | 6.35 | 290% |
Returns for 5 years | N/A | 17.95 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ESGE | 34.17 | 0.02 | +0.06% |
iShares ESG Aware MSCI EM ETF | |||
ERET | 26.99 | N/A | N/A |
iShares Environmentally Aware Rl Est ETF | |||
EOCT | 25.99 | -0.01 | -0.04% |
Innovator Emerg Mkts Pwr Bffr ETF™-Oct | |||
IJAN | 30.89 | -0.18 | -0.56% |
Innovator Itnl Dvp Pwr Buff ETF™ Jan | |||
IHE | 66.93 | -1.24 | -1.82% |
iShares US Pharmaceuticals ETF |